Granulocyte function in human allogenic marrow graft recipients

Area of Science:

• Immunology
• Hematology
• Transplantation Medicine

Background:

• Allogeneic marrow transplantation is a life-saving procedure for various hematologic malignancies and other diseases.
• Graft-versus-host disease (GVHD) and infections are significant complications following transplantation.
• Granulocyte function, including chemotaxis, is critical for immune defense against pathogens.

Purpose of the Study:

• To investigate granulocyte chemotaxis and iodination in allogeneic marrow transplant recipients.
• To assess the impact of time post-transplantation, graft-versus-host disease (GVHD), and infections on granulocyte function.
• To determine if impaired granulocyte function contributes to increased infection risk in transplant recipients.

Main Methods:

• Study included 87 allogeneic marrow transplant recipients and 25 healthy controls.
• Granulocyte chemotaxis and iodination assays were performed.
• Data were analyzed based on time post-transplantation, presence/severity of GVHD, and infections.

Main Results:

• Granulocyte chemotaxis was depressed in the early period (first 4 months) post-transplantation, normalizing in long-term survivors.
• Patients with moderate to severe acute or chronic GVHD or infections exhibited lower chemotactic responses.
• Granulocyte iodination and serum's ability to support iodination remained normal in recipients.

Conclusions:

• Depressed granulocyte chemotaxis following allogeneic marrow transplantation shows slow recovery over time.
• Both acute and chronic GVHD are associated with impaired granulocyte chemotaxis.
• Impaired granulocyte chemotaxis in GVHD patients may contribute to their heightened susceptibility to infections.